Onderzoeksoutput

Onderzoeksoutput per jaar 2023 2023 2024 2024

• 2 Citaties
• 1 h-index
• 9 Poster
• 2 Article
• 1 Unpublished abstract

Onderzoeksoutput per jaar

Onderzoeksoutput per jaar

Zoekresultaten

• 2024

  THERAPEUTIC TARGETING OF TUMOR-ASSOCIATED MACROPHAGES WITH ANTI-CD163 NANOBODY-DRUG CONJUGATES AS NOVEL CANCER THERAPY

  Maksymova, L., Van Ginderachter, J., Vincke, C., Raes, G., Van Craenenbroeck, J., Devoogdt, N. & De Groof, T., 21 mei 2024.

  Onderzoeksoutput: Poster

• The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages.

  Lauwers, Y., Devoogdt, N., De Groof, T., Raes, G., Van Ginderachter, J., Van Craenenbroeck, J. & Vincke, C., 15 mrt 2024, (Unpublished).

  Onderzoeksoutput: Poster

• The use of a CD163-specific nanobody-based immunotracer as an imaging agent to study immunosuppressive tumor-associated macrophages.

  Lauwers, Y., De Groof, T., Vincke, C., Van Craenenbroeck, J., Raes, G., Devoogdt, N. & Van Ginderachter, J., 30 mei 2024, (Submitted).

  Onderzoeksoutput: Poster
• 2023

  Characterization of CD163-specific nanobody-based immunotracers for non-invasive imaging of immunosuppressive macrophages

  Lauwers, Y., De Groof, T., Emami, M., Vincke, C., Van Craenenbroeck, J., Raes, G., Van Ginderachter, J. & Devoogdt, N., 16 okt 2023.

  Onderzoeksoutput: Poster

• Characterization of CD163-specific nanobody-based immunotracers for non-invasive imaging of immunosuppressive macrophages.

  Lauwers, Y., De Groof, T., Emami, M., Vincke, C., Van Craenenbroeck, J., Raes, G., Van Ginderachter, J. & Devoogdt, N., 2023.

  Onderzoeksoutput: Poster

  • Single-Domain Antibodies 100%
  • Immunosuppressive Agents 56%
  • Macrophages 47%
  • CD163 antigen 18%
  • Immunotherapy 12%

• Development of TAM-Targeted Therapies with Novel Nanobodies Against CD163

  Maksymova, L., Van Craenenbroeck, J., Lauwers, Y., Haji Assadi, A., Raes, G., De Groof, T., Vincke, C., Devoogdt, N. & Van Ginderachter, J., 2023.

  Onderzoeksoutput: Poster

• The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages

  Lauwers, Y., Devoogdt, N., De Groof, T., Vincke, C., Raes, G., Van Ginderachter, J. & Van Craenenbroeck, J., 5 okt 2023, (In preparation).

  Onderzoeksoutput: Poster

  • Single-Domain Antibodies 100%
  • Immunosuppressive Agents 56%
  • Macrophages 47%
  • Neoplasms 21%
  • CD163 antigen 19%

• The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages

  Lauwers, Y., De Groof, T., Van Craenenbroeck, J., Van Ginderachter, J., Vincke, C., Devoogdt, N. & Raes, G., 22 nov 2023, (Unpublished).

  Onderzoeksoutput: Poster

• The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages

  Lauwers, Y., De Groof, T., Emami, M., Vincke, C., Van Craenenbroeck, J., Raes, G., Van Ginderachter, J. & Devoogdt, N., 19 okt 2023.

  Onderzoeksoutput: Poster